CrossrefInfokarte
Impact of diabetes on the effects of SGLT2 inhibitors on kidney outcomes: An updated drug/dose-dependent meta-analysis
Clinical Nephrology · 2026-02-01 · 105 (2) · 128-149
DOI: 10.5414/cn111749 ↗Abstract
Kein Abstract verfügbar.
EUVIMED